Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

Condition:   Esophageal Cancer Interventions:   Drug: Lerotinib;   Drug: Irinotecan/Tegafur Sponsor:   Sunshine Lake Pharma Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials